Eric M. Green, president, chief executive officer and chair of West Pharmaceutical Services, informed the board of his intention to retire from all three positions once a successor is hired, the company announced on March 9, 2026.
Green notified the board on March 6 of his plans to step down to ensure a smooth leadership transition. The board has engaged a leading executive recruiting firm to conduct the search for his replacement, with the company expecting the transition to occur in the second half of 2026.
West Pharmaceutical reaffirmed its 2026 financial guidance as part of the announcement. The company, which manufactures pharmaceutical packaging and delivery systems, is headquartered in Exton, Pennsylvania and trades on the New York Stock Exchange under the ticker WST.
The leadership change comes as the company continues to navigate market conditions in the healthcare sector. No details were provided regarding Green’s tenure or reasons for his retirement decision.
Disclaimer: This article is based on a Form 8-K filing submitted to the U.S. Securities and Exchange Commission (SEC).
This article is written by AI Desk and reviewed by News Desk before publication.
Comments are closed.